Skip to Content
Merck
CN

Structure-activity relationship studies of curcumin analogues.

Bioorganic & medicinal chemistry letters (2009-03-03)
James R Fuchs, Bulbul Pandit, Deepak Bhasin, Jonathan P Etter, Nicholas Regan, Dalia Abdelhamid, Chenglong Li, Jiayuh Lin, Pui-Kai Li
ABSTRACT

Two series of curcumin analogues, a total of twenty-four compounds, were synthesized and evaluated. The most potent compound, compound 23, showed potent growth inhibitory activities on both prostate and breast cancer lines with IC(50) values in sub-micromolar range, fifty times more potent than curcumin. Curcumin analogues might be potential anti-tumor agents for breast and prostate cancers.

MATERIALS
Product Number
Brand
Product Description

Supelco
Bisdemethoxycurcumin, analytical standard